Celltrion’s COVID-19 Treatment Regdanvimab Is Approved In Korea

Follows Conditional Approval In February From Korean Regulator

 
• By Dean Rudge
  
South Korea flag waving against clean blue sky, close up, isolated with clipping path mask alpha channel transparency
The EMA is currently evaluating regdanvimab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin